Sehul P

Q: What is Sehul P email address?

Email Sehul P at sehul.p@alvogen.com. This email is the most updated Sehul P email found in 2026.

Q: How to contact Sehul P?

To contact Sehul P send an email to sehul.p@alvogen.com. (updated on November 04, 2024)

Medical Director at Alvogen | New York City Metropolitan Area

About Sehul P

Sehul P. currently serves as the Medical Director at Alvogen, where he leverages his extensive expertise in international drug surveillance and patient safety to enhance the company’s pharmacovigilance efforts. With a robust background in clinical trials and a focus on oncology, Sehul is instrumental in developing and implementing risk management plans (RMPs) that prioritize patient safety while navigating the complexities of drug development. His deep understanding of aggregate reporting and benefit-risk assessment allows him to effectively identify and mitigate potential risks associated with biopharmaceutical products, ensuring compliance with regulatory standards set forth by the U.S. Food and Drug Administration (FDA).

In his role, Sehul leads key projects that involve patient case classification and signal detection, utilizing his proficiency in MedDRA and WHO-Drug coding to provide comprehensive medical expertise in the assessment of individual cases. His commitment to patient safety is evident in his proactive approach to risk management, where he collaborates with cross-functional teams to develop strategic risk mitigation strategies that align with Alvogen’s mission to deliver innovative therapies.

Sehul’s passion for improving patient outcomes extends beyond his immediate responsibilities; he actively engages in mentoring emerging professionals in the field of pharmacovigilance, sharing insights on best practices and the importance of a patient-centered approach in drug development. His contributions not only enhance Alvogen’s operational capabilities but also reinforce the company’s dedication to advancing healthcare solutions for patients battling conditions such as leukemia and lymphedema. Through his leadership, Sehul P. continues to drive excellence in patient safety and clinical development, making a significant impact in the biopharmaceutical industry.

Sehul P Work